| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243255 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 4 Pages |
Abstract
Conclusion: Bevacizumab, alone and in combination with other agents, can reduce radiation necrosis by decreasing capillary leakage and the associated brain edema. Our findings will need to be confirmed in a randomized trial to determine the optimal duration of treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Javier M.D., Ashok J. M.D., Charles A. M.D., Victor A. M.D.,